Tropheryma whipplei and Whipple's disease

Journal of Infection

Volumn 69, Issue 2, 2014, Pages 103-112

  Fenollar, Florence ^a,b   Lagier, Jean Christophe ^a,b   Raoult, Didier ^a,b  

^a AIX MARSEILLE UNIVERSITÉ   (France)

^b TIMONE HOSPITAL   (France)

Author keywords

Encephalitis; Endocarditis; Gastroenteritis; Tropheryma whipplei; Whipple's disease

Indexed keywords

COTRIMOXAZOLE; DOXYCYCLINE; HYDROXYCHLOROQUINE; MINOCYCLINE; ANTIINFECTIVE AGENT;

ARTHRITIS; ASYMPTOMATIC INFECTION; BACTEREMIA; BACTERIAL TRANSMISSION; BACTERIOLOGY; COMMUNITY ACQUIRED PNEUMONIA; DISEASE ASSOCIATION; DISEASE SEVERITY; DUODENUM BIOPSY; ENCEPHALITIS; ENDOCARDITIS; FECES ANALYSIS; GASTROENTERITIS; HIP PROSTHESIS; HUMAN; IMMUNOHISTOCHEMISTRY; INTERVERTEBRAL DISK DEGENERATION; INTESTINE LIPODYSTROPHY; KNEE PROSTHESIS; PATHOPHYSIOLOGY; PREVALENCE; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; REVIEW; SALIVA ANALYSIS; SEROPREVALENCE; SEWAGE TREATMENT PLANT; SYSTEMIC DISEASE; TROPHERYMA WHIPPELII; UVEITIS; WASTE WATER; WESTERN BLOTTING; ACUTE DISEASE; FECES; ISOLATION AND PURIFICATION; MICROBIOLOGY; PNEUMONIA; POLYMERASE CHAIN REACTION; SALIVA; TROPHERYMA; WHIPPLE DISEASE;

ACUTE DISEASE; ANTI-BACTERIAL AGENTS; BACTEREMIA; ENDOCARDITIS; FECES; GASTROENTERITIS; HUMANS; PNEUMONIA; POLYMERASE CHAIN REACTION; SALIVA; TROPHERYMA; WHIPPLE DISEASE;

EID: 84903433545     PISSN: 01634453     EISSN: 15322742     Source Type: Journal    
DOI: 10.1016/j.jinf.2014.05.008     Document Type: Review

References (59)

1. Relman D.A., Schmidt T.M., MacDermott R.P., Falkow S. Identification of the uncultured bacillus of Whipple's disease. N Engl J Med 1992, 327(5):293-301.
2. Whipple G.H. A hitherto undescribed disease characterized anatomically by deposits of fat and fatty acids in the intestinal and mesenteric lymphatic tissues. Bull Johns Hopkins Hosp 1907, 18:382-391.
3. Fenollar F., Puéchal X., Raoult D. Whipple's disease. N Engl J Med 2007, 356(1):55-66.
4. Schneider T., Moos V., Loddenkemper C., Marth T., Fenollar F., Raoult D. Whipple's disease: new aspects of pathogenesis and treatment. Lancet Infect Dis 2008, 8(3):179-190.
5. Li W., Fenollar F., Rolain J.M., Fournier P.E., Feurle G.E., Müller C., et al. Genotyping reveals a wide heterogeneity of Tropheryma whipplei. Microbiology 2008, 154(2):521-527.
6. Fenollar F., Laouira S., Lepidi H., Rolain J.M., Raoult D. Value of Tropheryma whipplei quantitative PCR assay for the diagnosis of Whipple's disease: usefulness of saliva and stool specimens for first-line screening. Clin Infect Dis 2008, 47(5):659-667.
7. Bakkali N., Fenollar F., Biswas S., Rolain J.M., Raoult D. Acquired resistance to trimethoprim-sulfamethoxazole during Whipple's disease and expression of the causative target gene. J Infect Dis 2008, 198(1):101-108.
8. Bentley S.D., Maiwald M., Murphy L.D., Pallen M.J., Yeats C.A., Dover L.G., et al. Sequencing and analysis of the genome of the Whipple's disease bacterium Tropheryma whipplei. Lancet 2003, 361(9358):637-644.
9. Moos V., Schneider T. Changing paradigms in Whipple's disease and infection with Tropheryma whipplei. Eur J Clin Microbiol Infect Dis 2011, 30(10):1151-1158.
10. Raoult D., Fenollar F., Rolain J.M., Minodier P., Bosdure E., Li W., et al. Tropheryma whipplei in children with gastroenteritis. Emerg Infect Dis 2010, 16(5):776-782.
11. Fenollar F., Keita A.K., Buffet S., Raoult D. Intrafamilial circulation of Tropheryma whipplei, France. Emerg Infect Dis 2012, 18(6):949-955.
12. Keita A.K., Brouqui P., Badiaga S., Benkouiten S., Ratmanov P., Raoult D., et al. Tropheryma whipplei prevalence strongly suggests human transmission in homeless shelters. Int J Infect Dis 2013, 17(1):e67-e68.
13. Keita A.K., Bassene H., Tall A., Sokhna C., Ratmanov P., Trape J.F., et al. Tropheryma whipplei: a common bacterium in rural Senegal. PLoS Neglect Trop Dis 2011, 5(12):1403.
14. Lagier J.C., Lepidi H., Raoult D., Fenollar F. Systemic Tropheryma whipplei: clinical presentation of 142 patients with infections diagnosed or confirmed in a reference center. Med Baltim 2010, 89(5):337-345.
15. Bousbia S., Papazian L., Auffray J.P., Fenollar F., Martin C., Li W., et al. Tropheryma whipplei in patients with pneumonia. Emerg Infect Dis 2010, 16(2):258-263.
16. Fenollar F., Mediannikov O., Socolovschi C., Bassene H., Diatta G., Richet H., et al. Tropheryma whipplei bacteremia during fever in rural West Africa. Clin Infect Dis 2010, 51(5):515-521.
17. Keita A.K., Raoult D., Fenollar F. Tropheryma whipplei as a commensal bacterium. Future Microbiol 2013, 8(1):57-71.
18. Fenollar F., Amphoux B., Raoult D. A paradoxical Tropheryma whipplei western blot differentiates patients with Whipple's disease from asymptomatic carriers. Clin Infect Dis 2009, 49(5):717-723.
19. Fenollar F., Ponge T., La Scola B., Lagier J.C., Lefebvre M., Raoult D. First isolation of Tropheryma whipplei from bronchoalveolar fluid and clinical implications. J Infect 2011, 65(3):275-278.
20. Wetzstein N., Fenollar F., Buffet S., Moos V., Schneider T., Raoult D. Tropheryma whipplei genotypes 1 and 3, in central Europe. Emerg Infect Dis 2013, 19(2):341-342.
21. Keita A.K., Mediannikov O., Ratmanov P., Diatta G., Bassene H., Roucher C., et al. Looking for Tropheryma whipplei source and reservoir in rural Senegal. Am J Trop Med Hyg 2013, 88(2):339-343.
22. Merhej V., Royer-Carenzi M., Pontarotti P., Raoult D. Massive comparative genomic analysis reveals convergent evolution of specialized bacteria. Biol Direct 2009, 4:13.
23. Harris J.K., De Groote M.A., Sagel S.D., Zemanick E.T., Kapsner R., Penvari C., et al. Molecular identification of bacteria in bronchoalveolar lavage fluid from children with cystic fibrosis. Proc Natl Acad Sci U S A 2007, 104(51):20529-20533.
24. Lozupone C., Cota-Gomez A., Palmer B.E., Linderman D.J., Charlson E.S., Sodergren E., et al. Widespread colonization of the lung by Tropheryma whipplei in HIV infection. Am J Respir Crit Care Med 2013, 187(10):1110-1117.
25. Stein A., Doutchi M., Fenollar F., Raoult D. Tropheryma whipplei pneumonia in a patient with HIV-2 infection. Am J Respir Crit Care Med 2013, 188(8):1036-1037.
26. Gautret P., Benkouiten S., Parola P., Brouqui P., Memish Z., Raoult D. Occurrence of Tropheryma whipplei during diarrhea in Hajj pilgrims : a PCR analysis of paired rectal swabs. Travel Med Infect Dis 2014, 12(3):264-267.
27. Al Moussawi K., Malou N., Mege J.L., Raoult D., Desnues B. An experimental Mouse model to establish Tropheryma whipplei as a diarrheal agent. J Infect Dis 2011, 204(1):44-50.
28. Geissdörfer W., Moos V., Moter A., Loddenkemper C., Jansen A., Tandler R., et al. High frequency of Tropheryma whipplei in culture-negative endocarditis. J Cin Microbiol 2012, 50(2):216-222.
29. Mahnel R., Kalt A., Ring S., Stallmach A., Strober W., Marth T. Immunosuppressive therapy in Whipple's disease patients is associated with the appearance of gastrointestinal manifestations. Am J Gastroenterol 2005, 100(5):1167-1173.
30. Le Dolley Y., Habib G., Lepidi H., Fenollar F., Raoult D. Severe Whipple's disease with acute myocarditis. Int J Cardiol 2012, 159(2):e41-e42.
31. Schoenberger S.D., Thinda S., Kim S.J. Tropheryma whipplei crystalline keratopathy: report of a case and updated review of the literature. Case Rep Ophthalmol Med 2012, 2012:707898.
32. Urbanski G., Rivereau P., Artru L., Fenollar F., Raoult D., Puéchal X. Whipple disease revealed by lung involvement: a case report and literature review. Chest 2012, 141(6):1595-1598.
33. Touitou V., Fenollar F., Cassoux N., Merle-Beral H., LeHoang P., Amoura Z., et al. Ocular Whipple's disease: therapeutic strategy and long-term follow-up. Ophthalmology 2012, 119(7):1465-1469.
34. Fenollar F., Celard M., Lagier J.C., Lepidi H., Fournier P.E., Raoult D. Tropheryma whipplei endocarditis: a 28 patient series and review. Emerg Infect Dis 2013, 19(11):1721-1730.
35. Lagier J.C., Fenollar F., Lepidi H., Giorgi R., Million M., Raoult D. Treatment of classic Whipple's disease: from invitro results to clinical outcome. J Antimicrob Chemother 2014, 69(1):219-227.
36. Fenollar F., Nicoli F., Paquet C., Lepidi H., Cozzone P., Antoine J.C., et al. Progressive dementia associated with ataxia or obesity in patients with Tropheryma whipplei encephalitis. BMC Infect Dis 2011, 11(1):171.
37. Lagier J.C., Fenollar F., Koric B., Guedj E., Ceccaldi M., Raoult D. Weight gain, dementia and ataxia susceptible to doxycycline: a probable supplementary case report caused by Tropheryma whipplei. Rev Med Interne 2013, 34(10):641-644.
38. Compain C., Sacre K., Puechal X., Klein I., Vital-Durand D., Houeto J.L., et al. Central nervous system involvement in Whipple disease: clinical study of 18 patients and long-term follow-up. Med Baltim 2013, 92(6):324-330.
39. Drancourt M., Fenollar F., Denis D., Raoult D. Postoperative panophthalmitis caused by Whipple disease. Emerg Infect Dis 2009, 15(5):825-827.
40. Cremniter J., Bauer T., Lortat-Jacob A., Vodovar D., Le Parc J.M., Emile J.F., et al. Prosthetic hip infection caused by Tropheryma whipplei. J Clin Microbiol 2008, 46(4):1556-1557.
41. Altwegg M., Fleisch-Marx A., Goldenberger D., Hailemariam S., Schaffner A., Kissling R. Spondylodiscitis caused by Tropheryma whippelii. Schweiz Med Wochenschr 1996, 126(35):1495-1499.
42. Durand D.V., Lecomte C., Cathébras P., Rousset H., Godeau P. The SNFMI Research Group On Whipple Disease. Societe Nationale Francaise de Medecine Interne. Whipple's disease-clinical review of 52 cases. Med Baltim 1997, 76(3):170-184.
43. Martineti M., Biagi F., Badulli C., Feurle G.E., Müller C., Moos V., et al. The HLA alleles DRB1*13 and DQB1*06 are associated to Whipple's disease. Gastroenterology 2009, 136(7):2289-2294.
44. Biagi F., Badulli C., Feurle G.E., Müller C., Moos V., Schneider T., et al. Cytokine genetic profile in Whipple's disease. Eur J Clin Microbiol Infect Dis 2012, 31(11):3145-3160.
45. Ponz de Leon M., Borghi A., Ferrara F., Contri M., Roncucci L. Whipple's disease in a father-son pair. Intern Emerg Med 2006, 1(3):254-256.
46. Lagier J.C., Fenollar F., Lepidi H., Raoult D. Evidence of lifetime susceptibility to Tropheryma whipplei in patients with Whipple's disease. J Antimicrob Chemother 2011, 66(5):1188-1189.
47. Moos V., Schneider T. The role of T cells in the pathogenesis of classical Whipple's disease. Expert Rev Anti Infect Ther 2012, 10(3):253-255.
48. Edouard S., Fenollar F., Raoult D. The rise of Tropheryma whipplei: a 12-year retrospective study of PCR diagnoses in our reference center. J Clin Microbiol 2012, 50(12):3917-3920.
49. Meunier M., Puechal X., Hoppe E., Soubrier M., Dieude P., Berthelot J.M., et al. Rheumatic and musculoskeletal features of Whipple disease: a report of 29 cases. J Rheumatol 2013, 40(12):2061-2066.
50. Feurle G.E., Junga N.S., Marth T. Efficacy of ceftriaxone or meropenem as initial therapies in Whipple's disease. Gastroenterology 2010, 138(2):478-486.
51. Fenollar F., Raoult D. How should classic Whipple's disease be managed?. Nat Rev Gastroenterol Hepatol 2010, 7(5):246-248.
52. Fenollar F., Rolain J.M., Alric L., Papo T., Chauveheid M.P., van de Beek D., et al. Resistance to trimethoprim/sulfamethoxazole and Tropheryma whipplei. Int J Antimicrob Agents 2009, 34(3):255-259.
53. Lagier J.C., Fenollar F., Lepidi H., Raoult D. Failure and relapse after treatment with trimethoprim-sulfamethoxazole in classic Whipple's disease. J Antimicrob Chemother 2010, 65(9):2005-2012.
54. Feurle G.E., Moos V., Schneider T., Fenollar F., Raoult D. The combination of chloroquine and minocycline, a therapeutic option in cerebrospinal infection of Whipple's disease refractory to treatment with ceftriaxone, meropenem and co-trimoxazole. J Antimicrob Chemother 2012, 67(5):1295-1296.
55. Fenollar F., Lagier J.C., Rolain J.M., Célard M., Bouchot O., Eicher J.C., et al. Tropheryma whipplei endocarditis relapses after treatment with trimethoprim-sulfamethoxazole. Int J Antimicrob Agents 2013, 41(6):592-594.
56. Fenollar F., Perreal C., Raoult D. Tropheryma whipplei natural resistance to trimethoprim and sulphonamides invitro. Int J Antimicrob Agents 2014, 43(4):388-390.
57. Feurle G.E., Moos V., Schinnerling K., Geelhaar A., Allers K., Biagi F., et al. The immune reconstitution inflammatory syndrome in Whipple disease: a cohort study. Ann Intern Med 2010, 153(11):710-717.
58. Lagier J.C., Fenollar F., Lepidi H., Liozon E., Raoult D. Successful treatment of immune reconstitution inflammatory syndrome in Whipple's disease using thalidomide. J Infect 2010, 60(1):79-82.
59. Feurle G.E., Moos V., Bläker H., Loddenkemper C., Moter A., Stroux A., et al. Intravenous ceftriaxone, followed by 12 or three months of oral treatment with trimethoprim-sulfamethoxazole in Whipple's disease. J Infect 2013, 66(3):263-270.